Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 MutationsJ. Clin. Oncol 2022 Oct 26;[EPub Ahead of Print], PK Brastianos, EL Twohy, ER Gerstner, TJ Kaufmann, AJ Iafrate, J Lennerz, S Jeyapalan, DE Piccioni, V Monga, CE Fadul, D Schiff, JW Taylor, SA Chowdhary, C Bettegowda, G Ansstas, M De La Fuente, MD Anderson, N Shonka, D Damek, J Carrillo, LJ Kunschner-Ronan, R Chaudhary, KA Jaeckle, FM Senecal, T Kaley, T Morrison, AA Thomas, MR Welch, F Iwamoto, D Cachia, AL Cohen, S Vora, M Knopp, IF Dunn, P Kumthekar, J Sarkaria, S Geyer, XW Carrero, M Martinez-Lage, DP Cahill, PD Brown, C Giannini, S Santagata, FG Barker, E Galanis
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.